Cargando…
Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management—An Insight into Future Approaches
Vascular thrombosis and pregnancy morbidity represent the clinical manifestations of antiphospholipid syndrome (APS), which is serologically characterized by the persistent positivity of antiphospholipid antibodies (aPL). Antiplatelet and anticoagulant agents currently provide the mainstay of APS tr...
Autores principales: | Chighizola, Cecilia Beatrice, Ubiali, Tania, Meroni, Pier Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436516/ https://www.ncbi.nlm.nih.gov/pubmed/26075289 http://dx.doi.org/10.1155/2015/951424 |
Ejemplares similares
-
Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers
por: Meroni, Pier Luigi, et al.
Publicado: (2014) -
Pathogenic Role of Complement in Antiphospholipid Syndrome and Therapeutic Implications
por: Tedesco, Francesco, et al.
Publicado: (2018) -
Pediatric Antiphospholipid Syndrome: from Pathogenesis to Clinical Management
por: Rosina, Silvia, et al.
Publicado: (2021) -
Clinical Management of Thrombotic Antiphospholipid Syndrome
por: Tumian, Nor Rafeah, et al.
Publicado: (2022) -
Role of antiphospholipid antibodies in the diagnosis of antiphospholipid syndrome
por: Devreese, Katrien M.J., et al.
Publicado: (2021)